{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T12:23:26Z","timestamp":1793881406908,"version":"4.7.0"},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2021,11,10]],"date-time":"2021-11-10T00:00:00Z","timestamp":1636502400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"},{"start":{"date-parts":[[2021,11,10]],"date-time":"2021-11-10T00:00:00Z","timestamp":1636502400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,11,10]],"date-time":"2021-11-10T00:00:00Z","timestamp":1636502400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>IgA nephropathy (IgAN) has been anecdotally reported in association with atypical hemolytic uremic syndrome (aHUS). The association likely portends poor renal outcome, and the possible relationship with complement overactivation has yet to be elucidated. We evaluated a series of IgAN patients with aHUS and reviewed the available literature.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Adult patients who received a diagnosis of IgAN and developed aHUS between January 2009 and December 2019 were included\u00a0in this retrospective review.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We identified six IgAN-aHUS patients, all of whom developed end-stage kidney disease. At aHUS presentation all patients had decreased serum C3 levels. Predisposing pathogenetic variants and risk haplotypes for aHUS in CFH gene heterozygosity were documented in four out of six patients. Anti-CFH antibodies were found to be negative in the five tested patients. In the literature we identified 21 case reports involving aHUS-IgAN and six retrospective studies evaluating the presence of TMA at the time of renal biopsy. Hypertension, severe proteinuria, reduced sC3 and a worse renal prognosis were the common features of most cases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our case series and literature review show that the onset of either aHUS or renal TMA in the course of IgAN are associated with very poor renal outcome. Activation of the alternative pathway revealed by consumption of serum C3 seems to play a major role. Our hypothesis is that the presence of a predisposing factor (e.g. dysregualtion of complement alternative pathway and\/or other intrarenal precipitating factors) might be at the heart of aHUS-IgAN pathophysiology.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1007\/s40620-021-01189-6","type":"journal-article","created":{"date-parts":[[2021,11,10]],"date-time":"2021-11-10T08:02:39Z","timestamp":1636531359000},"page":"1091-1100","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["IgA nephropathy and atypical hemolytic uremic syndrome: a case series and a literature review"],"prefix":"10.1093","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4144-2142","authenticated-orcid":false,"given":"Lucio","family":"Manenti","sequence":"first","affiliation":[{"name":"Dipartimento di Medicina e Chirurgia, Universit\u00e0 di Parma e UO Nefrologia, Azienda Ospedaliero-Universitaria di Parma, Via Gramsci 14, 43126, Parma, Italy 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni Maria","family":"Rossi","sequence":"additional","affiliation":[{"name":"Dipartimento di Medicina e Chirurgia, Universit\u00e0 di Parma e UO Nefrologia, Azienda Ospedaliero-Universitaria di Parma, Via Gramsci 14, 43126, Parma, Italy 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Pisani","sequence":"additional","affiliation":[{"name":"Dipartimento di Medicina e Chirurgia, Universit\u00e0 di Parma e UO Nefrologia, Azienda Ospedaliero-Universitaria di Parma, Via Gramsci 14, 43126, Parma, Italy 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micaela","family":"Gentile","sequence":"additional","affiliation":[{"name":"Dipartimento di Medicina e Chirurgia, Universit\u00e0 di Parma e UO Nefrologia, Azienda Ospedaliero-Universitaria di Parma, Via Gramsci 14, 43126, Parma, Italy 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Fontana","sequence":"additional","affiliation":[{"name":"UO Nefrologia e Dialisi, Azienda Ospedaliero Universitaria di Modena, Modena, Italy 2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco Paolo","family":"Pilato","sequence":"additional","affiliation":[{"name":"UO di Anatomia Patologica, Azienda Ospedaliero Universitaria di Parma, Parma, Italy 3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Delsante","sequence":"additional","affiliation":[{"name":"Dipartimento di Medicina e Chirurgia, Universit\u00e0 di Parma e UO Nefrologia, Azienda Ospedaliero-Universitaria di Parma, Via Gramsci 14, 43126, Parma, Italy 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Ricco","sequence":"additional","affiliation":[{"name":"Dipartimento di Medicina e Chirurgia, Universit\u00e0 di Parma e UO Nefrologia, Azienda Ospedaliero-Universitaria di Parma, Via Gramsci 14, 43126, Parma, Italy 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renzo","family":"Mignani","sequence":"additional","affiliation":[{"name":"UO Nefrologia e Dialisi, Azienda Unit\u00e0 Sanitaria Locale della Romagna, Rimini, Italy 4"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Mele","sequence":"additional","affiliation":[{"name":"Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Ranica, Bergamo, Italy 5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Bresin","sequence":"additional","affiliation":[{"name":"Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Ranica, Bergamo, Italy 5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Fiaccadori","sequence":"additional","affiliation":[{"name":"Dipartimento di Medicina e Chirurgia, Universit\u00e0 di Parma e UO Nefrologia, Azienda Ospedaliero-Universitaria di Parma, Via Gramsci 14, 43126, Parma, Italy 1"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,11,10]]},"reference":[{"key":"2026012107592916500_CR1","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1016\/j.kint.2017.02.003","article-title":"Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group","volume":"91","author":"Trimarchi","year":"2017","journal-title":"Kidney Int"},{"key":"2026012107592916500_CR2","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1681\/ASN.2014101000","article-title":"Current understanding of the role of complement in IgA nephropathy","volume":"26","author":"Maillard","year":"2015","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"2026012107592916500_CR3","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1007\/s40620-020-00938-3","article-title":"Renal thrombotic microangiopathy associated to worse renal prognosis in Lupus Nephritis","volume":"34","author":"Strufaldi","year":"2021","journal-title":"J Nephrol"},{"key":"2026012107592916500_CR4","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1056\/NEJMra0902814","article-title":"Atypical hemolytic uremic syndrome","volume":"361","author":"Noris","year":"2009","journal-title":"N Engl J Med"},{"key":"2026012107592916500_CR5","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.1093\/ndt\/gft220","article-title":"Atypical haemolytic uraemic syndrome with underlying glomerulopathies. A case series and a review of the literature","volume":"28","author":"Manenti","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"2026012107592916500_CR6","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.molimm.2016.01.010","article-title":"Complement gene variants determine the risk of immunoglobulin-associated MPGN and C3 glomerulopathy and predict long-term renal outcome","volume":"71","author":"Iatropoulos","year":"2016","journal-title":"Mol Immunol"},{"issue":"12","key":"2026012107592916500_CR7","doi-asserted-by":"publisher","first-page":"3385","DOI":"10.1093\/hmg\/ddg363","article-title":"Complement factor H mutations and gene polymorphisms in haemolytic uraemic syndrome: the C-257T, the A2089G and the G2881T polymorphisms are strongly associated with the disease","volume":"15","author":"Caprioli","year":"2003","journal-title":"Hum Mol Genet"},{"issue":"1","key":"2026012107592916500_CR8","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1093\/hmg\/ddi066","article-title":"Predisposition to atypical hemolytic uremic syndrome involves the concurrence of different susceptibility alleles in the regulators of complement activation gene cluster in 1q32","volume":"2005","author":"Esparza-Gordillo","year":"2005","journal-title":"Hum Mol Genet"},{"issue":"269\u2013273","key":"2026012107592916500_CR9","first-page":"10","article-title":"A case of HUS with IgA deposition of mesangio-capillary type","volume":"48","author":"Okabe","year":"1985","journal-title":"J Ped Pract"},{"key":"2026012107592916500_CR10","first-page":"777","article-title":"A case of IgA nephropathy progressed to CRF with association of HUS","volume":"29","author":"Hoshii","year":"1990","journal-title":"Jin to Touseki"},{"key":"2026012107592916500_CR11","doi-asserted-by":"publisher","first-page":"495","DOI":"10.2169\/internalmedicine.38.495","article-title":"Hemolytic uremic syndrome associated with immunoglobulin A nephropathy: a case report and review of cases of hemolytic uremic syndrome with glomerular disease","volume":"38","author":"Morita","year":"1999","journal-title":"Intern Med"},{"issue":"8","key":"2026012107592916500_CR12","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1111\/j.1600-6143.2008.02297.x","article-title":"Complement mutation-associated de novo thrombotic microangiopathy following kidney transplantation","volume":"2008","author":"Le Quintrec","year":"2008","journal-title":"Am J Transplant"},{"key":"2026012107592916500_CR13","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.2215\/CJN.02210310","article-title":"Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype","volume":"5","author":"Noris","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026012107592916500_CR14","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s00431-010-1279-3","article-title":"IgA nephropathy associated with a novel N-terminal mutation in factor H","volume":"170","author":"Schmitt","year":"2011","journal-title":"Eur J Pediatr"},{"key":"2026012107592916500_CR15","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.transci.2012.06.018","article-title":"Hemolytic-uremic syndrome, malignant hypertension and IgA nephropathy: successful treatment with plasma exchange therapy","volume":"47","author":"Pipili","year":"2012","journal-title":"Transfus Apher Sci"},{"key":"2026012107592916500_CR16","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1038\/ki.2013.322","article-title":"The Case. Renal dysfunction in a pregnant patient with IgA nephropathy","volume":"85","author":"Zand","year":"2014","journal-title":"Kidney Int"},{"key":"2026012107592916500_CR17","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.nephro.2014.10.001","article-title":"PTT ou SHU atypique ? \u00c0 propos d\u2019un cas r\u00e9v\u00e9lant une maladie de Berger [TTP or HUS? About a case revealing an IgA nephropathy]","volume":"10","author":"Isnard","year":"2014","journal-title":"Nephrol Ther"},{"key":"2026012107592916500_CR18","doi-asserted-by":"publisher","first-page":"36","DOI":"10.5414\/CN108000","article-title":"Hemolytic uremic syndrome complicated with IgA nephropathy: a case report and literature review","volume":"83","author":"Wang","year":"2015","journal-title":"Clin Nephrol"},{"key":"2026012107592916500_CR19","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S1001-9294(15)30045-6","article-title":"Postpartum atypical hemolytic uremic syndrome: an unusual and severe complication associated with IgA nephropathy","volume":"30","author":"Sun","year":"2015","journal-title":"Chin Med Sci J"},{"key":"2026012107592916500_CR20","doi-asserted-by":"publisher","first-page":"42","DOI":"10.4103\/0971-4065.163423","article-title":"Plasma exchange in Immunoglobulin A nephropathy with thrombotic microangiopathy and acute cortical necrosis","volume":"26","author":"Doddi","year":"2016","journal-title":"Indian J Nephrol"},{"key":"2026012107592916500_CR21","first-page":"24","article-title":"Coexistence of atypical hemolytic uremic syndrome and crescentic IgA nephropathy treated with eculizumab: a case report","volume":"4","author":"Matsumura","year":"2016","journal-title":"Clin Nephrol Case Stud"},{"key":"2026012107592916500_CR22","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1159\/000470852","article-title":"A rare presentation of immunoglobulin a nephropathy: acute kidney injury","volume":"137","author":"Oruc","year":"2017","journal-title":"Nephron"},{"key":"2026012107592916500_CR23","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1159\/000485194","article-title":"Atypical hemolytic uremic syndrome associated with complement factor H mutation and IgA nephropathy: a case report successfully treated with eculizumab","volume":"138","author":"Nakamura","year":"2018","journal-title":"Nephron"},{"key":"2026012107592916500_CR24","doi-asserted-by":"publisher","first-page":"81","DOI":"10.24953\/turkjped.2018.01.012","article-title":"Hemolytic uremic syndrome and IgA nephropathy in a child: coincidence or not?","volume":"60","author":"S\u00fcrmeli-D\u00f6ven","year":"2018","journal-title":"Turk J Pediatr"},{"key":"2026012107592916500_CR25","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1684\/ejd.2018.3285","article-title":"Bullous pemphigoid accompanied by IgA nephropathy and atypical haemolytic uraemic syndrome","volume":"28","author":"Oya","year":"2018","journal-title":"Eur J Dermatol"},{"key":"2026012107592916500_CR26","doi-asserted-by":"publisher","DOI":"10.1007\/s40620-020-00846-6 32870493","article-title":"Lessons for the clinical nephrologist: an uncommon cause of pulmonary-renal syndrome","author":"Binet","year":"2021","journal-title":"J Nephrol"},{"key":"2026012107592916500_CR27","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1681\/ASN.2010111130","article-title":"A clinicopathologic study of thrombotic microangiopathy in IgA nephropathy","volume":"23","author":"El Karoui","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"2026012107592916500_CR28","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1053\/j.ajkd.2019.03.416","article-title":"Microangiopathic lesions in IgA nephropathy: a cohort study","volume":"74","author":"Cai","year":"2019","journal-title":"Am J Kidney Dis"},{"issue":"e0233199","key":"2026012107592916500_CR29","first-page":"2020","article-title":"Evidences of histologic thrombotic microangiopathy and the impact in renal outcomes of patients with IgA nephropathy","volume":"15","author":"Neves","year":"2020","journal-title":"PLoS ONE"},{"key":"2026012107592916500_CR30","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1159\/000489290","article-title":"Intrarenal arterial lesions are associated with higher blood pressure, reduced renal function and poorer renal outcomes in patients with IgA nephropathy","volume":"43","author":"Zhang","year":"2018","journal-title":"Kidney Blood Press Res"},{"key":"2026012107592916500_CR31","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1038\/s41379-019-0259-z","article-title":"Complement-mediated microangiopathy in IgA nephropathy and IgA vasculitis with nephritis","volume":"32","author":"Chua","year":"2019","journal-title":"Mod Pathol"},{"key":"2026012107592916500_CR32","doi-asserted-by":"publisher","first-page":"397","DOI":"10.5414\/CNP66397","article-title":"A clinicopathologic study of thrombotic microangiopathy in the setting of IgA nephropathy","volume":"66","author":"Chang","year":"2006","journal-title":"Clin Nephrol"},{"key":"2026012107592916500_CR33","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1161\/HYPERTENSIONAHA.119.13714","article-title":"Diagnostic and risk factors for complement defects in hypertensive emergency and thrombotic microangiopathy","volume":"75","author":"Timmermans","year":"2020","journal-title":"Hypertension"},{"issue":"Suppl 1","key":"2026012107592916500_CR34","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/nep.12937","article-title":"Absence of thrombocytopaenia and\/or microangiopathic haemolytic anaemia does not reliably exclude recurrence of atypical haemolytic uraemic syndrome after kidney transplantation","volume":"22","author":"Krishnan","year":"2017","journal-title":"Nephrology (Carlton)"},{"key":"2026012107592916500_CR35","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1093\/ndt\/gfn687","article-title":"Athrombocytopenic thrombotic microangiopathy, a condition that could be overlooked based on current diagnostic criteria","volume":"24","author":"De Serres","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"2026012107592916500_CR36","doi-asserted-by":"publisher","first-page":"e0177894","DOI":"10.1371\/journal.pone.0177894","article-title":"Predictive features of chronic kidney disease in atypical haemolytic uremic syndrome","volume":"12","author":"Jamme","year":"2017","journal-title":"PLoS ONE"},{"key":"2026012107592916500_CR37","doi-asserted-by":"publisher","first-page":"R12","DOI":"10.1186\/ar4142","article-title":"The spectrum of renal thrombotic microangiopathy in lupus nephritis","volume":"15","author":"Song","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"2026012107592916500_CR38","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/nrneph.2014.250","article-title":"Podocyte dysfunction in atypical haemolytic uraemic syndrome","volume":"11","author":"Noris","year":"2015","journal-title":"Nat Rev Nephrol"},{"key":"2026012107592916500_CR39","doi-asserted-by":"publisher","first-page":"e4049540","DOI":"10.1371\/annotation\/f6ebe3d3-ef7c-42ce-86fe-d5a661d7f67f","article-title":"Decreased circulating C3 levels and mesangial C3 deposition predict renal outcome in patients with IgA nephropathy","volume":"7","author":"Kim","year":"2012","journal-title":"PLoS ONE"},{"key":"2026012107592916500_CR40","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.2169\/internalmedicine.43.1023","article-title":"Relationship between serum IgA\/C3 ratio and progression of IgA nephropathy","volume":"43","author":"Komatsu","year":"2004","journal-title":"Intern Med"},{"key":"2026012107592916500_CR41","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/nep.12010","article-title":"Serum immunoglobulin A\/C3 ratio predicts progression of immunoglobulin A nephropathy","volume":"18","author":"Zhang","year":"2013","journal-title":"Nephrology Carlton"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-021-01189-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40620-021-01189-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/joneph\/article-pdf\/35\/4\/1091\/66407243\/joneph_35_4_1189.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-021-01189-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/academic.oup.com\/joneph\/article-pdf\/35\/4\/1091\/66407243\/joneph_35_4_1189.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T12:59:35Z","timestamp":1769000375000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/35\/4\/1091\/8325682"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,10]]},"references-count":41,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,11,10]]},"published-print":{"date-parts":[[2022,5,1]]}},"URL":"https:\/\/doi.org\/10.1007\/s40620-021-01189-6","relation":{},"ISSN":["1121-8428","1724-6059"],"issn-type":[{"value":"1121-8428","type":"print"},{"value":"1724-6059","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,4,1]]},"published":{"date-parts":[[2021,11,10]]},"assertion":[{"value":"14 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the authors have no conflict of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was part of a protocol approved by the Azienda Ospedaliera-Universitaria of Parma (Parma, Italy) ethics committee and all patients provided informed consent to be enrolled in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}